Proteins involved in the transport of NUCLEOSIDES across cellular membranes.
A class of sodium-independent nucleoside transporters that mediate the facilitative transport of NUCLEOSIDES.
Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
Sulfhydryl analog of INOSINE that inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p503)
A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties.
Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.
Uridine is a nucleoside, specifically a derivative of pyrimidine, that is composed of a uracil molecule joined to a ribose sugar molecule through a β-N1 glycosidic bond, and has significant roles in RNA synthesis, energy transfer, and cell signaling.
Coronary vasodilator with some antiarrhythmic activity.
A subtype of equilibrative nucleoside transporter proteins that is sensitive to inhibition by 4-nitrobenzylthioinosine.
The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
A subtype of equilibrative nucleoside transporter proteins that is insensitive to inhibition by 4-nitrobenzylthioinosine.
Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES.
An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.
Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS.
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.
A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
Transport proteins that carry specific substances in the blood or across cell membranes.
A broad category of membrane transport proteins that specifically transport FREE FATTY ACIDS across cellular membranes. They play an important role in LIPID METABOLISM in CELLS that utilize free fatty acids as an energy source.
A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
Nucleosides in which the base moiety is substituted with one or more sulfur atoms.
Thymidine is a pyrimidine nucleoside, consisting of a thymine base linked to a deoxyribose sugar by a β-N1-glycosidic bond, which plays a crucial role in DNA replication and repair processes as one of the four nucleosides in DNA.
The rate dynamics in chemical or physical systems.
Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
Leukemia L1210 is a designation for a specific murine (mouse) leukemia cell line that was originally isolated from a female mouse with an induced acute myeloid leukemia, which is widely used as a model in cancer research, particularly for in vivo studies of drug efficacy and resistance.
Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.
A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology.
A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.
A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.
Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.
A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.
2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system.
An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES.
A purine base and a fundamental unit of ADENINE NUCLEOTIDES.
A triphosphate nucleotide analog which is the biologically active form of CYTARABINE. It inhibits nuclear DNA synthesis.
Drugs that inhibit ADENOSINE DEAMINASE activity.
Tritium is an isotope of hydrogen (specifically, hydrogen-3) that contains one proton and two neutrons in its nucleus, making it radioactive with a half-life of about 12.3 years, and is used in various applications including nuclear research, illumination, and dating techniques due to its low energy beta decay.
A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.
The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.
Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
Dimethylformamide (DMF) is an organic compound, commonly used as a solvent, which is not typically considered a medication or therapeutic agent in clinical medicine.
Membrane proteins whose primary function is to facilitate the transport of positively charged molecules (cations) across a biological membrane.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
The movement of ions across energy-transducing cell membranes. Transport can be active, passive or facilitated. Ions may travel by themselves (uniport), or as a group of two or more ions in the same (symport) or opposite (antiport) directions.
Membrane proteins whose primary function is to facilitate the transport of negatively charged molecules (anions) across a biological membrane.

[3H]gemcitabine uptake by nucleoside transporters in a human head and neck squamous carcinoma cell line. (1/189)

Cellular uptake of many chemotherapeutic nucleoside analogs is dependent on the activity of a family of nucleoside transport proteins located in the cell plasma membrane. In the present study, we examined the role of these transporters in the accumulation of gemcitabine by a human head and neck squamous carcinoma cell line. The uptake of [3H]gemcitibine was compared with that of [3H]uridine and [3H]formycin B in the parent cell line (HN-5a) and in a gemcitabine-resistant variant (GEM-8e). The HN-5a and GEM-8e cells were similar in their transport characteristics and expressed predominantly the es (equilibrative, inhibitor-sensitive) transporter subtype; less than 10% of the influx of [3H]formycin B or [3H]uridine was mediated by the ei (equilibrative inhibitor-resistant) system, and there was no evidence for Na+-dependent nucleoside transporters. [3H]Gemcitabine (10 microM) entered these cells via both the es and ei transporters with an initial rate of uptake similar to that seen with the use of [3H]formycin B or [3H]uridine. In addition, ATP-replete cells accumulated significantly less [3H]gemcitabine than did ATP-depleted cells, which is indicative of an active efflux mechanism for gemcitabine. These results show that gemcitabine is a substrate for both the es and ei nucleoside transporters of HN-5a and GEM-8e cells and that gemcitabine resistance of the GEM-8e cells cannot be attributed to changes in transporter activity. Further studies to define the characteristics of the putative efflux mechanism are clearly warranted because this system has the potential to significantly affect the clinical efficacy of gemcitabine.  (+info)

Nucleoside transport in human colonic epithelial cell lines: evidence for two Na+-independent transport systems in T84 and Caco-2 cells. (2/189)

RT-PCR of RNA isolated from monolayers of the human colonic epithelial cell lines T84 and Caco-2 demonstrated the presence of mRNA for the two cloned Na+-independent equilibrative nucleoside transporters, ENT1 and ENT2, but not for the cloned Na+-dependent concentrative nucleoside transporters, CNT1 and CNT2. Uptake of [3H]uridine by cell monolayers in balanced Na+-containing and Na+-free media confirmed the presence of only Na+-independent nucleoside transport mechanisms. This uptake was decreased by 70-75% in the presence of 1 microM nitrobenzylthioinosine, a concentration that completely inhibits ENT1, and was completely blocked by the addition of 10 microM dipyridamole, a concentration that inhibits both ENT1 and ENT2. These findings indicate the presence in T84 and Caco-2 cells of two functional Na+-independent equilibrative nucleoside transporters, ENT1 and ENT2.  (+info)

Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models. (3/189)

The antineoplastic efficacy of P-4055, a 5'-elaidic acid (C18:1, unsaturated fatty acid) ester of cytarabine, a nucleoside antimetabolite frequently used in the treatment of hematological malignancies, was examined in several in vivo models for human cancer. In initial dose-finding studies in nude mice, the efficacy of P-4055 was highest when using schedules with repeated daily doses. In a Raji Burkitt's lymphoma leptomeningeal carcinomatosis model in nude rats, the control cytarabine- and saline-treated animals (five in each group) had a mean survival time of 13.2 days, whereas treatment with P-4055 resulted in three of five long-time survivors (>70 days). In a systemic Raji leukemia model in nude mice, 8 of 10 of the P-4055-treated animals survived (>80 days), compared with none of the cytarabine-treated animals (mean survival time, 34.2 days). In s.c. xenograft models, the effects of maximum tolerated doses of P-4055 and cytarabine, given in four weekly cycles of daily bolus i.v. injections for 5 subsequent days, against seven tumors (three melanomas, one lung adenocarcinoma, one breast cancer, and two osteogenic sarcomas) were investigated. P-4055 induced partial or complete tumor regression of the lung carcinoma, as well as of all three malignant melanomas. In two of the melanomas the activity was highly superior to that of cytarabine, and both P-4055 and cytarabine were, in general, more effective than several clinically established drugs previously tested in the same tumor models. In in vitro studies, inhibitors of nucleoside carrier-dependent transport, nitrobenzylmercaptopurine riboside and dipyridamol, reduced strongly the cellular sensitivity to cytarabine, but not to P-4055, indicating that P-4055 uses an alternative/additional mechanism of internalization into the cell compared with cytarabine. The results explain, at least in part, the observed differences between the two compounds in in vivo efficacy, and together the data strongly support the evaluation of P-4055 in clinical studies.  (+info)

A nucleoside transporter from Trypanosoma brucei involved in drug resistance. (4/189)

Drug resistance of pathogens is an increasing problem whose underlying mechanisms are not fully understood. Cellular uptake of the major drugs against Trypanosoma brucei spp., the causative agents of sleeping sickness, is thought to occur through an unusual, so far unidentified adenosine transporter. Saccharomyces cerevisiae was used in a functional screen to clone a gene (TbAT1) from Trypanosoma brucei brucei that encodes a nucleoside transporter. When expressed in yeast, TbAT1 enabled adenosine uptake and conferred susceptibility to melaminophenyl arsenicals. Drug-resistant trypanosomes harbor a defective TbAT1 variant. The molecular identification of the entry route of trypanocides opens the way to approaches for diagnosis and treatment of drug-resistant sleeping sickness.  (+info)

Uptake of NO-releasing drugs by the P2 nucleoside transporter in trypanosomes. (5/189)

Nitric oxide (NO.) has been identified as a principal regulatory molecule of the immune system and the major cytotoxic mediator of activated immune cells. NO. can also react rapidly with a variety of biological species, particularly with the superoxide radical anion O2.- at almost diffusion-limited rates to form peroxynitrite anion (ONOO-). ONOO- and its proton-catalyzed decomposition products are capable of oxidizing a great diversity of biomolecules and can act as a source of toxic hydroxyl radicals. As a consequence, a strategy for the development of molecules with potential trypanocidal activities could be developed to increase the concentration of nitric oxide in the parasites through NO.-releasing compounds. In this way, the rate of formation of peroxynitrite from NO. and O2.- would be faster than the rate of dismutation of superoxide radicals by superoxide dismutases which constitute the primary antioxidant enzymatic defense system in trypanosomes. The adenosine transport systems of parasitic protozoa, which are also in certain cases implicated in the selective uptake of active drugs such as melarsoprol or pentamidine, could be exploited to specifically target these NO.-releasing compounds inside the parasites. In this work, we present the synthesis, characterization and biological evaluation of a series of molecules that contain both a group which would specifically target these drugs inside the parasites via the purine transporter, and an NO.-donor group that would exert a specific pharmacological effect by increasing NO level, and thus the peroxynitrite concentration inside the parasite.  (+info)

A Na(+)-dependent nucleoside transporter in microglia. (6/189)

In the central nervous system, HIV-1 has a defined tropism for brain macrophages and microglia. Nucleoside analog drugs such as zidovudine improve the clinical and neuropsychological functions in HIV-demented patients. Multiple carrier-mediated transport systems can play an important role in the membrane permeation of nucleosides and nucleoside analog drugs in a number of cells. The purpose of this project was to characterize the uptake properties of the pyrimidine nucleoside probe thymidine by a continuous rat microglia cell line (MLS-9) grown as a monolayer on an impermeable substratum. Approximately 50% of thymidine (10 microM) uptake by the monolayer cells was found to be Na(+) dependent. Kinetics of specific thymidine uptake showed a single saturation system (K(m) = 44 microM at 37 degrees C) and a Na(+)/thymidine stoichiometry of 2:1. Pyrimidine and purine nucleoside probes (50 microM) exerted a competitive inhibitory effect on specific thymidine uptake with K(i) values of 40, 38, 45, and 39 microM for adenosine, uridine, guanosine, and cytidine, respectively. In addition, nucleoside analog drugs significantly decreased specific thymidine uptake, with IC(50) values of 135.1 microM for abacavir and 0.6 microM for zidovudine, which inhibited in a noncompetitive manner. These results suggest that a Na(+)-dependent nucleoside transport system is present in rat microglia and that long-range interactions between antiretroviral nucleoside analog drugs and the nucleoside substrates may occur at the transporter sites.  (+info)

Nitric oxide regulates nucleoside transport in activated B lymphocytes. (7/189)

Activation of human B lymphocytes by lipopolysaccharide (LPS) or phorbol 12-myristate 13-acetate (PMA) results in the differential regulation of nucleoside uptake [Soler, C., Felipe, A., Mata, J. F., Casado, F. J., Celada, A., Pastor-Anglada, M. (1998) J. Biol. Chem. 273, 26939-26945]. Because nitric oxide (NO) is involved in the modulation of the apoptotic response of B cells, the effects of NO on the regulatory responses of these transport systems to phorbol esters has been studied in Raji cells by a combination of approaches that involve arginine depletion, inhibition of nitric oxide synthase, and non-enzymatic production of NO using a donor. Human B lymphocytes express three transport systems involved in nucleoside uptake: N1 and N5, which are concentrative and Na+-dependent, and the nitrobenzylthioinosine-sensitive equilibrative system es. Raji cells do not express significant amounts of iNOS mRNA or protein; thus, NO production is presumably constitutive. The data are consistent with a role of NO in maintaining the basal transport activities of the three systems: N1, N5, and es. However, the up-regulatory effect of PMA on N1 and N5 does not require NO, whereas the inhibition of es transport activity does. In summary, NO differentially modulates nucleoside transport systems in activated human B lymphocytes and thus, NO may also be involved in the regulation of nucleoside (i.e., adenosine) disposal by activated B cells.  (+info)

Cloning of a novel inosine-guanosine transporter gene from Leishmania donovani by functional rescue of a transport-deficient mutant. (8/189)

Purine transport is an indispensable nutritional function for protozoan parasites, since they are incapable of purine biosynthesis and must, therefore, acquire purines from the host milieu. Exploiting a mutant cell line (FBD5) of Leishmania donovani deficient in inosine and guanosine transport activity, the gene encoding this transporter (LdNT2) has been cloned by functional rescue of the mutant phenotype. LdNT2 encodes a polypeptide of 499 amino acids that shows substantial homology to other members of the equilibrative nucleoside transporter family. Molecular analysis revealed that LdNT2 is present as a single gene copy within the leishmanial genome and encodes a single transcript of 3 kilobase pairs. Transfection of FBD5 parasites with LdNT2 re-established their ability to take up inosine and guanosine with a concurrent restoration of sensitivity to the inosine analog formycin B. Kinetic analyses reveal that LdNT2 is highly specific for inosine (K(m) = 0.3 micrometer) and guanosine (K(m) = 1.7 micrometer) and does not recognize other naturally occurring nucleosides. Expression of LdNT2 cRNA in Xenopus oocytes significantly augmented their ability to take up inosine and guanosine, establishing that LdNT2 by itself suffices to mediate nucleoside transport. These results authenticate genetically and biochemically that LdNT2 is a novel nucleoside transporter with an unusual and strict specificity for inosine and guanosine.  (+info)

Nucleoside transport proteins (NTTs) are membrane-bound proteins responsible for the facilitated diffusion of nucleosides and related deoxynucleosides across the cell membrane. These proteins play a crucial role in the uptake of nucleosides, which serve as precursors for DNA and RNA synthesis, as well as for the salvage of nucleotides in the cell.

There are two main types of NTTs: concentrative (or sodium-dependent) nucleoside transporters (CNTs) and equilibrative (or sodium-independent) nucleoside transporters (ENTs). CNTs mainly facilitate the uptake of nucleosides against a concentration gradient, using the energy derived from the sodium ion gradient. In contrast, ENTs mediate bidirectional transport, allowing for the equalization of intracellular and extracellular nucleoside concentrations.

Nucleoside transport proteins have been identified in various organisms, including humans, and are involved in numerous physiological processes, such as cell proliferation, differentiation, and survival. Dysregulation of NTTs has been implicated in several pathological conditions, including cancer and viral infections, making them potential targets for therapeutic intervention.

Equilibrative nucleoside transport proteins (ENTs) are a type of membrane transporter that regulate the bidirectional movement of nucleosides across the cell membrane. They facilitate the diffusion of nucleosides down their concentration gradient, hence the term "equilibrative." These transport proteins play a crucial role in maintaining intracellular nucleoside concentrations and ensuring proper nucleotide synthesis for various cellular processes, including DNA replication, repair, and gene expression. There are two major families of ENTs: the human equilibrative nucleoside transporters (hENTs) and the concentrative nucleoside transporters (CNTs). The hENT family includes four members (hENT1-4), while the CNT family consists of three members (CNT1-3). These transport proteins have been identified as potential targets for cancer therapy, as inhibiting their function can selectively sensitize tumor cells to nucleoside analog-based chemotherapies.

A nucleoside is a biochemical molecule that consists of a pentose sugar (a type of simple sugar with five carbon atoms) covalently linked to a nitrogenous base. The nitrogenous base can be one of several types, including adenine, guanine, cytosine, thymine, or uracil. Nucleosides are important components of nucleic acids, such as DNA and RNA, which are the genetic materials found in cells. They play a crucial role in various biological processes, including cell division, protein synthesis, and gene expression.

Thioinosine is not a medical term itself, but it is a chemical compound that has been studied in the field of medical research. Thioinosine is an analogue of the nucleoside inosine, where the oxygen atom in the heterocyclic ring is replaced by a sulfur atom.

In the context of medical research, thioinosine has been investigated for its potential immunomodulatory and antiviral properties. It has been studied as an inhibitor of certain enzymes involved in the replication of viruses, such as HIV and hepatitis C virus. However, it is not currently approved for use as a medication in clinical practice.

Inosine is not a medical condition but a naturally occurring compound called a nucleoside, which is formed from the combination of hypoxanthine and ribose. It is an intermediate in the metabolic pathways of purine nucleotides, which are essential components of DNA and RNA. Inosine has been studied for its potential therapeutic benefits in various medical conditions, including neurodegenerative disorders, cardiovascular diseases, and cancer. However, more research is needed to fully understand its mechanisms and clinical applications.

Formycins are a group of antibiotics that are derived from certain strains of Streptomyces bacteria. They include formycin B (also known as pyrazofurin), which is an antiviral and antimetabolite drug that works by interfering with the production of genetic material in cells. Formycins are not widely used in clinical medicine due to their potential toxicity and the availability of other effective antibiotics and antiviral drugs.

Purine nucleosides are fundamental components of nucleic acids, which are the genetic materials found in all living organisms. A purine nucleoside is composed of a purine base (either adenine or guanine) linked to a sugar molecule, specifically ribose in the case of purine nucleosides.

The purine base and sugar moiety are joined together through a glycosidic bond at the 1' position of the sugar. These nucleosides play crucial roles in various biological processes, including energy transfer, signal transduction, and as precursors for the biosynthesis of DNA and RNA.

In the human body, purine nucleosides can be derived from the breakdown of endogenous nucleic acids or through the dietary intake of nucleoproteins. They are further metabolized to form uric acid, which is eventually excreted in the urine. Elevated levels of uric acid in the body can lead to the formation of uric acid crystals and contribute to the development of gout or kidney stones.

Uridine is a nucleoside that consists of a pyrimidine base (uracil) linked to a pentose sugar (ribose). It is a component of RNA, where it pairs with adenine. Uridine can also be found in various foods such as beer, broccoli, yeast, and meat. In the body, uridine can be synthesized from orotate or from the breakdown of RNA. It has several functions, including acting as a building block for RNA, contributing to energy metabolism, and regulating cell growth and differentiation. Uridine is also available as a dietary supplement and has been studied for its potential benefits in various health conditions.

Dilazep is a medication that belongs to a class of drugs called calcium channel blockers. It is primarily used in the management of angina pectoris, which is chest pain caused by reduced blood flow to the heart muscle. Dilazep works by relaxing and widening the blood vessels that supply the heart, thereby improving blood flow and reducing the workload on the heart.

The chemical name for Dilazep is (E)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid diamide. It is not commonly used in many countries, and other calcium channel blockers such as verapamil, nifedipine, and amlodipine are more frequently prescribed for the treatment of angina pectoris.

It's important to note that like all medications, Dilazep can have side effects, including headache, dizziness, and swelling in the extremities. It should be used under the close supervision of a healthcare provider, who can monitor its effectiveness and potential side effects.

Equilibrative Nucleoside Transporter 1 (ENT1), also known as SLC29A1, is a protein that functions as a membrane transport protein. It is responsible for the facilitated diffusion of nucleosides and some related drugs across the cell membrane. The term "equilibrative" refers to the fact that this transporter moves substrates down their concentration gradient, meaning it facilitates the movement of molecules from an area of high concentration to an area of low concentration. ENT1 is widely expressed in various tissues, including the liver, kidney, intestine, and brain, playing a crucial role in nucleoside homeostasis and the cellular uptake of nucleoside-analog drugs used in cancer chemotherapy.

Biological transport refers to the movement of molecules, ions, or solutes across biological membranes or through cells in living organisms. This process is essential for maintaining homeostasis, regulating cellular functions, and enabling communication between cells. There are two main types of biological transport: passive transport and active transport.

Passive transport does not require the input of energy and includes:

1. Diffusion: The random movement of molecules from an area of high concentration to an area of low concentration until equilibrium is reached.
2. Osmosis: The diffusion of solvent molecules (usually water) across a semi-permeable membrane from an area of lower solute concentration to an area of higher solute concentration.
3. Facilitated diffusion: The assisted passage of polar or charged substances through protein channels or carriers in the cell membrane, which increases the rate of diffusion without consuming energy.

Active transport requires the input of energy (in the form of ATP) and includes:

1. Primary active transport: The direct use of ATP to move molecules against their concentration gradient, often driven by specific transport proteins called pumps.
2. Secondary active transport: The coupling of the movement of one substance down its electrochemical gradient with the uphill transport of another substance, mediated by a shared transport protein. This process is also known as co-transport or counter-transport.

Dipyridamole is a medication that belongs to a class of drugs called antiplatelet agents. It works by preventing platelets in your blood from sticking together to form clots. Dipyridamole is often used in combination with aspirin to prevent stroke and other complications in people who have had a heart valve replacement or a type of irregular heartbeat called atrial fibrillation.

Dipyridamole can also be used as a stress agent in myocardial perfusion imaging studies, which are tests used to evaluate blood flow to the heart. When used for this purpose, dipyridamole is given intravenously and works by dilating the blood vessels in the heart, allowing more blood to flow through them and making it easier to detect areas of reduced blood flow.

The most common side effects of dipyridamole include headache, dizziness, and gastrointestinal symptoms such as diarrhea, nausea, and vomiting. In rare cases, dipyridamole can cause more serious side effects, such as allergic reactions, abnormal heart rhythms, or low blood pressure. It is important to take dipyridamole exactly as directed by your healthcare provider and to report any unusual symptoms or side effects promptly.

Equilibrative Nucleoside Transporter 2 (ENT2) is a type of protein found in the cell membrane that facilitates the bidirectional transport of nucleosides, which are the building blocks of DNA and RNA, between the intracellular and extracellular spaces. ENT2 is a member of the solute carrier 29 (SLC29) family of transporters and is widely expressed in various tissues, including the brain, liver, kidney, and intestine.

ENT2 plays an essential role in maintaining nucleoside homeostasis by regulating their uptake and efflux across the cell membrane. It has a high affinity for purine nucleosides such as adenosine and guanosine, and to a lesser extent, pyrimidine nucleosides such as uridine and thymidine. The activity of ENT2 is critical in regulating extracellular adenosine levels, which have important implications for various physiological processes, including neurotransmission, inflammation, and cancer.

In addition to its role in nucleoside transport, ENT2 has been implicated in the development of drug resistance in cancer cells. Certain chemotherapeutic agents, such as nucleoside analogs, utilize ENT2 for their uptake into cells. However, overexpression of ENT2 in cancer cells can lead to increased efflux of these drugs, resulting in reduced intracellular concentrations and decreased therapeutic effectiveness. Therefore, ENT2 is an attractive target for the development of novel strategies to overcome drug resistance in cancer therapy.

Pyrimidine nucleosides are organic compounds that consist of a pyrimidine base (a heterocyclic aromatic ring containing two nitrogen atoms and four carbon atoms) linked to a sugar molecule, specifically ribose or deoxyribose, via a β-glycosidic bond. The pyrimidine bases found in nucleosides can be cytosine (C), thymine (T), or uracil (U). When the sugar component is ribose, it is called a pyrimidine nucleoside, and when it is linked to deoxyribose, it is referred to as a deoxy-pyrimidine nucleoside. These molecules play crucial roles in various biological processes, particularly in the structure and function of nucleic acids such as DNA and RNA.

Tubercidin is not a medical term itself, but it is a type of antibiotic that belongs to the class of compounds known as nucleoside antibiotics. Specifically, tubercidin is a naturally occurring adenine analogue that is produced by several species of Streptomyces bacteria.

Tubercidin has been found to have antimicrobial and antitumor activities. It works by inhibiting the enzyme adenosine deaminase, which plays a crucial role in the metabolism of nucleotides in cells. By inhibiting this enzyme, tubercidin can interfere with DNA and RNA synthesis, leading to cell death.

While tubercidin has shown promise as an anticancer agent in preclinical studies, its clinical use is limited due to its toxicity and potential for causing mutations in normal cells. Therefore, it is primarily used for research purposes to study the mechanisms of nucleotide metabolism and the effects of nucleoside analogues on cell growth and differentiation.

Membrane transport proteins are specialized biological molecules, specifically integral membrane proteins, that facilitate the movement of various substances across the lipid bilayer of cell membranes. They are responsible for the selective and regulated transport of ions, sugars, amino acids, nucleotides, and other molecules into and out of cells, as well as within different cellular compartments. These proteins can be categorized into two main types: channels and carriers (or pumps). Channels provide a passive transport mechanism, allowing ions or small molecules to move down their electrochemical gradient, while carriers actively transport substances against their concentration gradient, requiring energy usually in the form of ATP. Membrane transport proteins play a crucial role in maintaining cell homeostasis, signaling processes, and many other physiological functions.

Adenosine is a purine nucleoside that is composed of a sugar (ribose) and the base adenine. It plays several important roles in the body, including serving as a precursor for the synthesis of other molecules such as ATP, NAD+, and RNA.

In the medical context, adenosine is perhaps best known for its use as a pharmaceutical agent to treat certain cardiac arrhythmias. When administered intravenously, it can help restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT) by slowing conduction through the atrioventricular node and interrupting the reentry circuit responsible for the arrhythmia.

Adenosine can also be used as a diagnostic tool to help differentiate between narrow-complex tachycardias of supraventricular origin and those that originate from below the ventricles (such as ventricular tachycardia). This is because adenosine will typically terminate PSVT but not affect the rhythm of VT.

It's worth noting that adenosine has a very short half-life, lasting only a few seconds in the bloodstream. This means that its effects are rapidly reversible and generally well-tolerated, although some patients may experience transient symptoms such as flushing, chest pain, or shortness of breath.

Biological transport, active is the process by which cells use energy to move materials across their membranes from an area of lower concentration to an area of higher concentration. This type of transport is facilitated by specialized proteins called transporters or pumps that are located in the cell membrane. These proteins undergo conformational changes to physically carry the molecules through the lipid bilayer of the membrane, often against their concentration gradient.

Active transport requires energy because it works against the natural tendency of molecules to move from an area of higher concentration to an area of lower concentration, a process known as diffusion. Cells obtain this energy in the form of ATP (adenosine triphosphate), which is produced through cellular respiration.

Examples of active transport include the uptake of glucose and amino acids into cells, as well as the secretion of hormones and neurotransmitters. The sodium-potassium pump, which helps maintain resting membrane potential in nerve and muscle cells, is a classic example of an active transporter.

Guanosine is a nucleoside that consists of a guanine base linked to a ribose sugar molecule through a beta-N9-glycosidic bond. It plays a crucial role in various biological processes, such as serving as a building block for DNA and RNA during replication and transcription. Guanosine triphosphate (GTP) and guanosine diphosphate (GDP) are important energy carriers and signaling molecules involved in intracellular regulation. Additionally, guanosine has been studied for its potential role as a neuroprotective agent and possible contribution to cell-to-cell communication.

Carrier proteins, also known as transport proteins, are a type of protein that facilitates the movement of molecules across cell membranes. They are responsible for the selective and active transport of ions, sugars, amino acids, and other molecules from one side of the membrane to the other, against their concentration gradient. This process requires energy, usually in the form of ATP (adenosine triphosphate).

Carrier proteins have a specific binding site for the molecule they transport, and undergo conformational changes upon binding, which allows them to move the molecule across the membrane. Once the molecule has been transported, the carrier protein returns to its original conformation, ready to bind and transport another molecule.

Carrier proteins play a crucial role in maintaining the balance of ions and other molecules inside and outside of cells, and are essential for many physiological processes, including nerve impulse transmission, muscle contraction, and nutrient uptake.

Fatty acid transport proteins (FATPs) are a group of membrane-bound proteins that play a crucial role in the uptake and transport of long-chain fatty acids across the plasma membrane of cells. They are widely expressed in various tissues, including the heart, muscle, adipose tissue, and liver.

FATPs have several domains that enable them to perform their functions, including a cytoplasmic domain that binds to fatty acids, a transmembrane domain that spans the plasma membrane, and an ATP-binding cassette (ABC) domain that hydrolyzes ATP to provide energy for fatty acid transport.

FATPs also play a role in the regulation of intracellular lipid metabolism by modulating the activity of enzymes involved in fatty acid activation, desaturation, and elongation. Mutations in FATP genes have been associated with various metabolic disorders, including congenital deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD), a rare autosomal recessive disorder that affects fatty acid oxidation.

In summary, fatty acid transport proteins are essential for the uptake and metabolism of long-chain fatty acids in cells and have implications in various metabolic disorders.

Hypoxanthine is a purine derivative and an intermediate in the metabolic pathways of nucleotide degradation, specifically adenosine to uric acid in humans. It is formed from the oxidation of xanthine by the enzyme xanthine oxidase. In the body, hypoxanthine is converted to xanthine and then to uric acid, which is excreted in the urine. Increased levels of hypoxanthine in the body can be indicative of various pathological conditions, including tissue hypoxia, ischemia, and necrosis.

Thionucleosides are a type of modified nucleoside where the oxygen atom in the sugar component (ribose or deoxyribose) is replaced by a sulfur atom. This modification can occur naturally or be introduced synthetically. The resulting compounds have been studied for their potential biological activity, including antiviral and anticancer properties. However, they are not typically used as a standard medical treatment at this time.

Thymidine is a pyrimidine nucleoside that consists of a thymine base linked to a deoxyribose sugar by a β-N1-glycosidic bond. It plays a crucial role in DNA replication and repair processes as one of the four nucleosides in DNA, along with adenosine, guanosine, and cytidine. Thymidine is also used in research and clinical settings for various purposes, such as studying DNA synthesis or as a component of antiviral and anticancer therapies.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Ribonucleosides are organic compounds that consist of a nucleoside bound to a ribose sugar. Nucleosides are formed when a nitrogenous base (such as adenine, guanine, uracil, cytosine, or thymine) is attached to a sugar molecule (either ribose or deoxyribose) via a beta-glycosidic bond. In the case of ribonucleosides, the sugar component is D-ribose. Ribonucleosides play important roles in various biological processes, particularly in the storage, transfer, and expression of genetic information within cells. When ribonucleosides are phosphorylated, they become the building blocks of RNA (ribonucleic acid), a crucial biomolecule involved in protein synthesis and other cellular functions. Examples of ribonucleosides include adenosine, guanosine, uridine, cytidine, and inosine.

Leukemia L1210 is not a medical definition itself, but it refers to a specific mouse leukemia cell line that was established in 1948. These cells are a type of acute myeloid leukemia (AML) and have been widely used in cancer research as a model for studying the disease, testing new therapies, and understanding the biology of leukemia. The L1210 cell line has contributed significantly to the development of various chemotherapeutic agents and treatment strategies for leukemia and other cancers.

Hypoxanthine is not a medical condition but a purine base that is a component of many organic compounds, including nucleotides and nucleic acids, which are the building blocks of DNA and RNA. In the body, hypoxanthine is produced as a byproduct of normal cellular metabolism and is converted to xanthine and then uric acid, which is excreted in the urine.

However, abnormally high levels of hypoxanthine in the body can indicate tissue damage or disease. For example, during intense exercise or hypoxia (low oxygen levels), cells may break down ATP (adenosine triphosphate) rapidly, releasing large amounts of hypoxanthine. Similarly, in some genetic disorders such as Lesch-Nyhan syndrome, there is an accumulation of hypoxanthine due to a deficiency of the enzyme that converts it to xanthine. High levels of hypoxanthine can lead to the formation of kidney stones and other complications.

Affinity labels are chemical probes or reagents that can selectively and covalently bind to a specific protein or biomolecule based on its biological function or activity. These labels contain a functional group that interacts with the target molecule, often through non-covalent interactions such as hydrogen bonding, van der Waals forces, or ionic bonds. Once bound, the label then forms a covalent bond with the target molecule, allowing for its isolation and further study.

Affinity labels are commonly used in biochemistry and molecular biology research to identify and characterize specific proteins, enzymes, or receptors. They can be designed to bind to specific active sites, binding pockets, or other functional regions of a protein, allowing researchers to study the structure-function relationships of these molecules.

One example of an affinity label is a substrate analogue that contains a chemically reactive group. This type of affinity label can be used to identify and characterize enzymes by binding to their active sites and forming a covalent bond with the enzyme. The labeled enzyme can then be purified and analyzed to determine its structure, function, and mechanism of action.

Overall, affinity labels are valuable tools for studying the properties and functions of biological molecules in vitro and in vivo.

4-Chloromercuribenzenesulfonate is a chemical compound with the formula C6H5ClHgSO3. It is an organomercury compound, where mercury is bonded to a phenyl ring and a sulfonate group. This compound is an white crystalline powder that is soluble in water and denser than water.

It has been used historically as a diuretic and antiseptic, but its use in medicine has been discontinued due to the toxicity of mercury. Exposure to mercury can have serious health consequences, including damage to the nervous system, kidneys, and digestive system. Therefore, handling and disposal of 4-chloromercuribenzenesulfonate should be done with caution and in accordance with local regulations for hazardous materials.

Purines are heterocyclic aromatic organic compounds that consist of a pyrimidine ring fused to an imidazole ring. They are fundamental components of nucleotides, which are the building blocks of DNA and RNA. In the body, purines can be synthesized endogenously or obtained through dietary sources such as meat, seafood, and certain vegetables.

Once purines are metabolized, they are broken down into uric acid, which is excreted by the kidneys. Elevated levels of uric acid in the body can lead to the formation of uric acid crystals, resulting in conditions such as gout or kidney stones. Therefore, maintaining a balanced intake of purine-rich foods and ensuring proper kidney function are essential for overall health.

Deoxyadenosine is a chemical compound that is a component of DNA, one of the nucleic acids that make up the genetic material of living organisms. Specifically, deoxyadenosine is a nucleoside, which is a molecule consisting of a sugar (in this case, deoxyribose) bonded to a nitrogenous base (in this case, adenine).

Deoxyribonucleosides like deoxyadenosine are the building blocks of DNA, along with phosphate groups. In DNA, deoxyadenosine pairs with thymidine via hydrogen bonds to form one of the four rungs in the twisted ladder structure of the double helix.

It is important to note that there is a similar compound called adenosine, which contains an extra oxygen atom on the sugar molecule (making it a ribonucleoside) and is a component of RNA, another nucleic acid involved in protein synthesis and other cellular processes.

Coformycin is an antimetabolite antibiotic, which means it interferes with the growth of bacteria by inhibiting the synthesis of nucleic acids, the genetic material of bacteria. It is derived from Streptomyces coelicolor and is used primarily in research to study bacterial metabolism.

Coformycin is a potent inhibitor of bacterial enzyme adenosine deaminase, which is involved in purine biosynthesis. By inhibiting this enzyme, Coformycin prevents the bacteria from synthesizing the building blocks needed to make DNA and RNA, thereby inhibiting their growth.

Coformycin has not been approved for use as a therapeutic drug in humans or animals due to its narrow spectrum of activity and potential toxicity. However, it is still used in research settings to study bacterial metabolism and the mechanisms of antibiotic resistance.

Membrane proteins are a type of protein that are embedded in the lipid bilayer of biological membranes, such as the plasma membrane of cells or the inner membrane of mitochondria. These proteins play crucial roles in various cellular processes, including:

1. Cell-cell recognition and signaling
2. Transport of molecules across the membrane (selective permeability)
3. Enzymatic reactions at the membrane surface
4. Energy transduction and conversion
5. Mechanosensation and signal transduction

Membrane proteins can be classified into two main categories: integral membrane proteins, which are permanently associated with the lipid bilayer, and peripheral membrane proteins, which are temporarily or loosely attached to the membrane surface. Integral membrane proteins can further be divided into three subcategories based on their topology:

1. Transmembrane proteins, which span the entire width of the lipid bilayer with one or more alpha-helices or beta-barrels.
2. Lipid-anchored proteins, which are covalently attached to lipids in the membrane via a glycosylphosphatidylinositol (GPI) anchor or other lipid modifications.
3. Monotopic proteins, which are partially embedded in the membrane and have one or more domains exposed to either side of the bilayer.

Membrane proteins are essential for maintaining cellular homeostasis and are targets for various therapeutic interventions, including drug development and gene therapy. However, their structural complexity and hydrophobicity make them challenging to study using traditional biochemical methods, requiring specialized techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and single-particle cryo-electron microscopy (cryo-EM).

Sodium is an essential mineral and electrolyte that is necessary for human health. In a medical context, sodium is often discussed in terms of its concentration in the blood, as measured by serum sodium levels. The normal range for serum sodium is typically between 135 and 145 milliequivalents per liter (mEq/L).

Sodium plays a number of important roles in the body, including:

* Regulating fluid balance: Sodium helps to regulate the amount of water in and around your cells, which is important for maintaining normal blood pressure and preventing dehydration.
* Facilitating nerve impulse transmission: Sodium is involved in the generation and transmission of electrical signals in the nervous system, which is necessary for proper muscle function and coordination.
* Assisting with muscle contraction: Sodium helps to regulate muscle contractions by interacting with other minerals such as calcium and potassium.

Low sodium levels (hyponatremia) can cause symptoms such as confusion, seizures, and coma, while high sodium levels (hypernatremia) can lead to symptoms such as weakness, muscle cramps, and seizures. Both conditions require medical treatment to correct.

Pentostatin is a medication used in the treatment of certain types of cancer, including hairy cell leukemia and certain T-cell lymphomas. It is a type of drug called a purine nucleoside analog, which works by interfering with the production of DNA and RNA, the genetic material found in cells. This can help to stop the growth and multiplication of cancer cells.

Pentostatin is given intravenously (through an IV) in a healthcare setting, such as a hospital or clinic. It is usually administered on a schedule of every other week. Common side effects of pentostatin include nausea, vomiting, diarrhea, and loss of appetite. It can also cause more serious side effects, such as low blood cell counts, infections, and liver problems.

It's important to note that this is a medical definition of the drug and its use, and it should not be used as a substitute for professional medical advice. If you have any questions about pentostatin or your treatment, it is best to speak with your healthcare provider.

2-Chloroadenosine is a synthetic, chlorinated analog of adenosine, which is a naturally occurring purine nucleoside. It acts as an antagonist at adenosine receptors and has been studied for its potential effects on the cardiovascular system, including its ability to reduce heart rate and blood pressure. It may also have anti-cancer properties and has been investigated as a potential therapeutic agent in cancer treatment. However, further research is needed to establish its safety and efficacy in clinical settings.

Floxuridine is a chemotherapeutic antimetabolite medication that is primarily used in the treatment of colon cancer. It is a fluorinated pyrimidine nucleoside analogue, which means it is similar in structure to the building blocks of DNA and RNA, and can be incorporated into these molecules during cell division, disrupting their normal function and preventing cell replication.

Floxuridine works by inhibiting the enzyme thymidylate synthase, which is necessary for the synthesis of thymidine, a nucleoside that is essential for DNA replication. By blocking this enzyme, floxuridine can prevent the growth and proliferation of cancer cells.

Floxuridine is often used in combination with other chemotherapy drugs as part of a treatment regimen for colon cancer. It may be administered intravenously or via continuous infusion, depending on the specific treatment plan. As with all chemotherapy drugs, floxuridine can have significant side effects, including nausea, vomiting, diarrhea, and myelosuppression (suppression of bone marrow function), which can lead to anemia, neutropenia, and thrombocytopenia.

Monosaccharide transport proteins are a type of membrane transport protein that facilitate the passive or active transport of monosaccharides, such as glucose, fructose, and galactose, across cell membranes. These proteins play a crucial role in the absorption, distribution, and metabolism of carbohydrates in the body.

There are two main types of monosaccharide transport proteins: facilitated diffusion transporters and active transporters. Facilitated diffusion transporters, also known as glucose transporters (GLUTs), passively transport monosaccharides down their concentration gradient without the need for energy. In contrast, active transporters, such as the sodium-glucose cotransporter (SGLT), use energy in the form of ATP to actively transport monosaccharides against their concentration gradient.

Monosaccharide transport proteins are found in various tissues throughout the body, including the intestines, kidneys, liver, and brain. They play a critical role in maintaining glucose homeostasis by regulating the uptake and release of glucose into and out of cells. Dysfunction of these transporters has been implicated in several diseases, such as diabetes, cancer, and neurological disorders.

Adenine is a purine nucleotide base that is a fundamental component of DNA and RNA, the genetic material of living organisms. In DNA, adenine pairs with thymine via double hydrogen bonds, while in RNA, it pairs with uracil. Adenine is essential for the structure and function of nucleic acids, as well as for energy transfer reactions in cells through its role in the formation of adenosine triphosphate (ATP), the primary energy currency of the cell.

Arabinofuranosylcytosine triphosphate (Ara-C triphosphate) is a nucleotide analog that is formed from the conversion of arabinofuranosylcytosine (Ara-C) by deoxycytidine kinase in cells. It is an active metabolite of Ara-C, which is a chemotherapeutic drug used to treat various types of cancer, including leukemia and lymphoma.

Ara-C triphosphate works by getting incorporated into DNA during replication, causing the DNA synthesis process to stop, which leads to cell death. It has a higher affinity for DNA polymerase than normal nucleotides, allowing it to be preferentially incorporated into the DNA, leading to its anticancer effects.

Adenosine deaminase inhibitors are a class of medications that work by blocking the action of the enzyme adenosine deaminase. This enzyme is responsible for breaking down adenosine, a chemical in the body that helps regulate the immune system and is involved in the inflammatory response.

By inhibiting the activity of adenosine deaminase, these medications can increase the levels of adenosine in the body. This can be useful in certain medical conditions where reducing inflammation is important. For example, adenosine deaminase inhibitors are sometimes used to treat rheumatoid arthritis, a chronic autoimmune disease characterized by inflammation and damage to the joints.

One common adenosine deaminase inhibitor is called deoxycoformycin (also known as pentostatin). This medication is typically given intravenously and is used to treat hairy cell leukemia, a rare type of cancer that affects white blood cells.

It's important to note that adenosine deaminase inhibitors can have serious side effects, including suppression of the immune system, which can make people more susceptible to infections. They should only be used under the close supervision of a healthcare provider.

Tritium is not a medical term, but it is a term used in the field of nuclear physics and chemistry. Tritium (symbol: T or 3H) is a radioactive isotope of hydrogen with two neutrons and one proton in its nucleus. It is also known as heavy hydrogen or superheavy hydrogen.

Tritium has a half-life of about 12.3 years, which means that it decays by emitting a low-energy beta particle (an electron) to become helium-3. Due to its radioactive nature and relatively short half-life, tritium is used in various applications, including nuclear weapons, fusion reactors, luminous paints, and medical research.

In the context of medicine, tritium may be used as a radioactive tracer in some scientific studies or medical research, but it is not a term commonly used to describe a medical condition or treatment.

Trimetrexate is a antifolate drug, which means it interferes with the use of folic acid in the body. It is primarily used in the treatment of certain types of cancer and parasitic infections. Trimetrexate works by blocking the action of an enzyme called dihydrofolate reductase, which is necessary for the production of DNA and RNA, the genetic material found in cells. By inhibiting this enzyme, trimetrexate can help to stop the growth and multiplication of cancer cells or parasites.

In medical terms, Trimetrexate is classified as an antineoplastic agent and an antiprotozoal agent. It may be used to treat certain types of cancer such as non-Hodgkin's lymphoma, and it may also be used to treat parasitic infections caused by Pneumocystis jirovecii (formerly known as Pneumocystis carinii) in patients with weakened immune systems.

It is important to note that Trimetrexate can have significant side effects and should only be used under the close supervision of a healthcare provider.

A cell membrane, also known as the plasma membrane, is a thin semi-permeable phospholipid bilayer that surrounds all cells in animals, plants, and microorganisms. It functions as a barrier to control the movement of substances in and out of the cell, allowing necessary molecules such as nutrients, oxygen, and signaling molecules to enter while keeping out harmful substances and waste products. The cell membrane is composed mainly of phospholipids, which have hydrophilic (water-loving) heads and hydrophobic (water-fearing) tails. This unique structure allows the membrane to be flexible and fluid, yet selectively permeable. Additionally, various proteins are embedded in the membrane that serve as channels, pumps, receptors, and enzymes, contributing to the cell's overall functionality and communication with its environment.

Erythrocytes, also known as red blood cells (RBCs), are the most common type of blood cell in circulating blood in mammals. They are responsible for transporting oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs.

Erythrocytes are formed in the bone marrow and have a biconcave shape, which allows them to fold and bend easily as they pass through narrow blood vessels. They do not have a nucleus or mitochondria, which makes them more flexible but also limits their ability to reproduce or repair themselves.

In humans, erythrocytes are typically disc-shaped and measure about 7 micrometers in diameter. They contain the protein hemoglobin, which binds to oxygen and gives blood its red color. The lifespan of an erythrocyte is approximately 120 days, after which it is broken down in the liver and spleen.

Abnormalities in erythrocyte count or function can lead to various medical conditions, such as anemia, polycythemia, and sickle cell disease.

Cytarabine is a chemotherapeutic agent used in the treatment of various types of cancer, including leukemias and lymphomas. Its chemical name is cytosine arabinoside, and it works by interfering with the DNA synthesis of cancer cells, which ultimately leads to their death.

Cytarabine is often used in combination with other chemotherapy drugs and may be administered through various routes, such as intravenous (IV) or subcutaneous injection, or orally. The specific dosage and duration of treatment will depend on the type and stage of cancer being treated, as well as the patient's overall health status.

Like all chemotherapy drugs, cytarabine can cause a range of side effects, including nausea, vomiting, diarrhea, hair loss, and an increased risk of infection. It may also cause more serious side effects, such as damage to the liver, kidneys, or nervous system, and it is important for patients to be closely monitored during treatment to minimize these risks.

It's important to note that medical treatments should only be administered under the supervision of a qualified healthcare professional, and this information should not be used as a substitute for medical advice.

Dimethylformamide (DMF) is an organic compound with the formula (CH3)2NCHO. It is a colorless, hygroscopic liquid with a mild, characteristic odor. DMF is miscible with water and most organic solvents. It is widely used as a commercial solvent, due to its ability to dissolve both polar and non-polar compounds.

In the medical field, exposure to dimethylformamide can occur through inhalation, skin contact, or ingestion during its production, use, or disposal. Acute exposure to high levels of DMF may cause irritation to the eyes, skin, and respiratory tract. Chronic exposure has been associated with liver damage, neurological effects, and reproductive issues in both humans and animals.

It is essential to handle dimethylformamide with appropriate personal protective equipment (PPE), including gloves, safety glasses, and lab coats, to minimize exposure. Engineering controls, such as fume hoods, should also be used when working with this chemical to ensure adequate ventilation and reduce the risk of inhalation exposure.

Cation transport proteins are a type of membrane protein that facilitate the movement of cations (positively charged ions) across biological membranes. These proteins play a crucial role in maintaining ion balance and electrical excitability within cells, as well as in various physiological processes such as nutrient uptake, waste elimination, and signal transduction.

There are several types of cation transport proteins, including:

1. Ion channels: These are specialized protein structures that form a pore or channel through the membrane, allowing ions to pass through rapidly and selectively. They can be either voltage-gated or ligand-gated, meaning they open in response to changes in electrical potential or binding of specific molecules, respectively.

2. Ion pumps: These are active transport proteins that use energy from ATP hydrolysis to move ions against their electrochemical gradient, effectively pumping them from one side of the membrane to the other. Examples include the sodium-potassium pump (Na+/K+-ATPase) and calcium pumps (Ca2+ ATPase).

3. Ion exchangers: These are antiporter proteins that facilitate the exchange of one ion for another across the membrane, maintaining electroneutrality. For example, the sodium-proton exchanger (NHE) moves a proton into the cell in exchange for a sodium ion being moved out.

4. Symporters: These are cotransporter proteins that move two or more ions together in the same direction, often coupled with the transport of a solute molecule. An example is the sodium-glucose cotransporter (SGLT), which facilitates glucose uptake into cells by coupling its movement with that of sodium ions.

Collectively, cation transport proteins help maintain ion homeostasis and contribute to various cellular functions, including electrical signaling, enzyme regulation, and metabolic processes. Dysfunction in these proteins can lead to a range of diseases, such as neurological disorders, cardiovascular disease, and kidney dysfunction.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Ion transport refers to the active or passive movement of ions, such as sodium (Na+), potassium (K+), chloride (Cl-), and calcium (Ca2+) ions, across cell membranes. This process is essential for various physiological functions, including nerve impulse transmission, muscle contraction, and maintenance of resting membrane potential.

Ion transport can occur through several mechanisms, including:

1. Diffusion: the passive movement of ions down their concentration gradient, from an area of high concentration to an area of low concentration.
2. Facilitated diffusion: the passive movement of ions through specialized channels or transporters in the cell membrane.
3. Active transport: the energy-dependent movement of ions against their concentration gradient, requiring the use of ATP. This process is often mediated by ion pumps, such as the sodium-potassium pump (Na+/K+-ATPase).
4. Co-transport or symport: the coupled transport of two or more different ions or molecules in the same direction, often driven by an electrochemical gradient.
5. Counter-transport or antiport: the coupled transport of two or more different ions or molecules in opposite directions, also often driven by an electrochemical gradient.

Abnormalities in ion transport can lead to various medical conditions, such as cystic fibrosis (which involves defective chloride channel function), hypertension (which may be related to altered sodium transport), and certain forms of heart disease (which can result from abnormal calcium handling).

Anion transport proteins are specialized membrane transport proteins that facilitate the movement of negatively charged ions, known as anions, across biological membranes. These proteins play a crucial role in maintaining ionic balance and regulating various physiological processes within the body.

There are several types of anion transport proteins, including:

1. Cl-/HCO3- exchangers (also known as anion exchangers or band 3 proteins): These transporters facilitate the exchange of chloride (Cl-) and bicarbonate (HCO3-) ions across the membrane. They are widely expressed in various tissues, including the red blood cells, gastrointestinal tract, and kidneys, where they help regulate pH, fluid balance, and electrolyte homeostasis.
2. Sulfate permeases: These transporters facilitate the movement of sulfate ions (SO42-) across membranes. They are primarily found in the epithelial cells of the kidneys, intestines, and choroid plexus, where they play a role in sulfur metabolism and absorption.
3. Cl- channels: These proteins form ion channels that allow chloride ions to pass through the membrane. They are involved in various physiological processes, such as neuronal excitability, transepithelial fluid transport, and cell volume regulation.
4. Cation-chloride cotransporters: These transporters move both cations (positively charged ions) and chloride anions together across the membrane. They are involved in regulating neuronal excitability, cell volume, and ionic balance in various tissues.

Dysfunction of anion transport proteins has been implicated in several diseases, such as cystic fibrosis (due to mutations in the CFTR Cl- channel), distal renal tubular acidosis (due to defects in Cl-/HCO3- exchangers), and some forms of epilepsy (due to abnormalities in cation-chloride cotransporters).

Membrane Transport Proteins [D12.776.157.530]. *Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins [ ... Membrane Transport Proteins [D12.776.543.585]. *Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins [ ... and Nucleic Acid Transport Proteins*Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins ... "Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins" is a descriptor in the National Library of Medicines ...
Conserved Protein Domain Family Nucleos_tra2_N, This family consists of nucleoside transport proteins ... Na+ dependent nucleoside transporter N-terminus. This family consists of nucleoside transport proteins. Rat Slc28a2 is a purine ... Rat Slc28a1 is a a Na+-dependent nucleoside transporter selective for pyrimidine nucleosides and adenosine it also transports ... the anti-viral nucleoside analogues AZT and ddC. This alignment covers the N-terminus of this family ...
"Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein". The Journal of ... SLC28A1 is a Na+-dependent nucleoside transporter selective for pyrimidine nucleosides and adenosine. It also transports the ... Human concentrative nucleoside transporters include SLC28A1, SLC28A2 and SLC28A3 proteins. SLC28A2 is a purine-specific Na+- ... This article incorporates text from the public domain Pfam and InterPro: IPR011657 (Protein pages needing a picture, Protein ...
The protein is also thought to transport nucleosides into structures called mitochondria. , which are the energy-producing ... Researchers believe that this protein transports nucleosides generated by the breakdown of DNA and RNA out of lysosomes into ... Researchers speculate that the resulting impairment of nucleoside transport leads to a buildup of nucleosides in lysosomes, ... ENT3 belongs to a family of proteins that transport molecules called nucleosides in cells. With chemical modification, ...
Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. ... Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). Journal of Biological Chemistry, 276(49 ... The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer ... Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization ...
... and protein transport machinery, and one such protein, the major light-harvesting chlorophyll- binding protein (LHCP) exhibits ... We show that two members, Lhca1 and Lhcb5, display an absolute requirement for stroma, nucleoside triphosphates, and protein ... and protein transport machinery, and one such protein, the major light-harvesting chlorophyll- binding protein (LHCP) exhibits ... We show that two members, Lhca1 and Lhcb5, display an absolute requirement for stroma, nucleoside triphosphates, and protein ...
Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1). ...
Nucleoside Transport Proteins Medicine & Life Sciences 89% * Darunavir Medicine & Life Sciences 89% ... Multiple computational approaches for predicting drug interactions with human equilibrative nucleoside transporter 1s. In: Drug ... Multiple computational approaches for predicting drug interactions with human equilibrative nucleoside transporter 1s. Drug ... Multiple computational approaches for predicting drug interactions with human equilibrative nucleoside transporter 1s. / Miller ...
Nucleoside Transport Proteins Medicine & Life Sciences 100% * Purinergic P1 Receptors Medicine & Life Sciences 82% ... Initial studies demonstrated time-dependent repression of ENT1 and ENT2 transcript and protein levels during ALI. To examine ... Initial studies demonstrated time-dependent repression of ENT1 and ENT2 transcript and protein levels during ALI. To examine ... Initial studies demonstrated time-dependent repression of ENT1 and ENT2 transcript and protein levels during ALI. To examine ...
Nucleoside Transport Proteins 100% * Nucleoside 61% * Leishmania donovani 44% * Pharmacological Phenomena 25% ... Caught in the act -protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and disease. Thomas, G ... Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins. Davare, M. A., Saborowski, A., Eide, C. A., Tognon, C., ... Biochemical basis of regulation of human copper-transporting ATPases. Lutsenko, S., LeShane, E. S. & Shinde, U., Jul 15 2007, ...
nucleoside/purine/pyrimidine transport protein. 6e-08. 56.6. NC_013406:7024149:7048308. 7048308. 7048985. 678. Paenibacillus sp ... putative transport protein. 5e-09. 60.5. NC_003228:648669:671446. 671446. 672018. 573. Bacteroides fragilis NCTC 9343, complete ... putative transport protein. 4e-13. 73.9. NC_014931:2336465:2356113. 2356113. 2356733. 621. Variovorax paradoxus EPS chromosome ... Intergral membrane NMN transport protein. 1e-06. 52. NC_009615:4304158:4319349. 4319349. 4319936. 588. Parabacteroides ...
The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug ... nucleosides and sugars. ...
Nucleoside Transport Proteins Medicine & Life Sciences 46% View full fingerprint Cite this. * APA ... is auxotrophic for purines and has specialist nucleoside transporters to import these metabolites. In particular, the P2 ... is auxotrophic for purines and has specialist nucleoside transporters to import these metabolites. In particular, the P2 ... is auxotrophic for purines and has specialist nucleoside transporters to import these metabolites. In particular, the P2 ...
Nucleoside Transport Proteins Medicine & Life Sciences 40% * Dependovirus Medicine & Life Sciences 38% ...
Nucleoside Transport Proteins. Proteins involved in the transport of NUCLEOSIDES across cellular membranes.. ... Equilibrative Nucleoside Transport Proteins. A class of sodium-independent nucleoside transporters that mediate the ... Equilibrative-Nucleoside Transporter 2. A subtype of equilibrative nucleoside transporter proteins that is insensitive to ... Equilibrative Nucleoside Transporter 1. A subtype of equilibrative nucleoside transporter proteins that is sensitive to ...
Metabolism Transport and binding proteins Nucleosides, purines and pyrimidines GTP-binding protein (TIGR00991; HMM-score: 36) ... Metabolism Transport and binding proteins Cations and iron carrying compounds ferrous iron transport protein B (TIGR00437; HMM- ... Metabolism Transport and binding proteins Amino acids, peptides and amines LAO/AO transport system ATPase (TIGR00750; EC 2.7 ... Metabolism Transport and binding proteins Amino acids, peptides and amines urea ABC transporter, ATP-binding protein UrtE ( ...
Nucleoside transport ATP-binding protein (NCBI ptt file). 234, 283. BC3791. BC3791. Nucleoside-binding protein (NCBI ptt file) ... transport protein (NCBI ptt file). 79, 201. BC4405. BC4405. Protein translocase subunit SecD / Protein translocase subunit SecF ... ABC transporter substrate-binding protein (NCBI ptt file). 213, 283. BC5260. BC5260. hypothetical Exported Protein (NCBI ptt ... Multidrug resistance protein B (NCBI ptt file). 201, 312. BC4083. BC4083. Guanine-hypoxanthine permease (NCBI ptt file). 283, ...
Reid, G., et al., Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 ... Glutathione as a conjugation partner or co-transported substrate plays multiple and partially undefined roles in the transport ... polymorphisms can alter the expression level and the transport rate of the protein, and may influence therapeutic outcomes and ... MRP4 transports bile acids in the presence of glutathione (GSH), and functions as a backup system for eliminating bile acids ...
Inhibitors of Equilibrative Nucleoside (ENT1) and Concentrative Nucleoside (CNT3) Transport Proteins may increase the serum ... protein-bound(mainly to alpha-1-acid glycoprotein and albumin that has a higher affinity for alpha-1-acid glycoprotein). ... lopinavir component blocks the cleavage and synthesis of viral GagPol polyprotein precursors into the individual HIV proteins. ...
Equilibrative Nucleoside Transport Proteins D12.776.157.530.937.532 D12.776.543.585.937.563 Equilibrative Nucleoside ... Protein Transport G3.495.166.700 G3.143.700 Protein Unfolding G1.154.100.640.750 G1.154.651.750 G1.595.100.640.750 G2.111. ... ELAV Proteins D12.776.641.520 D12.776.631.520 ELAV-Like Protein 2 D12.776.641.520.500 D12.776.631.520.500 ELAV-Like Protein 3 ... PrP 27-30 Protein D12.776.785.700.700 D12.776.785.340.750.700 PrPC Proteins D12.776.785.680 D12.776.785.340.500 PrPSc Proteins ...
Equilibrative Nucleoside Transport Proteins D12.776.157.530.937.532 D12.776.543.585.937.563 Equilibrative Nucleoside ... Protein Transport G3.495.166.700 G3.143.700 Protein Unfolding G1.154.100.640.750 G1.154.651.750 G1.595.100.640.750 G2.111. ... ELAV Proteins D12.776.641.520 D12.776.631.520 ELAV-Like Protein 2 D12.776.641.520.500 D12.776.631.520.500 ELAV-Like Protein 3 ... PrP 27-30 Protein D12.776.785.700.700 D12.776.785.340.750.700 PrPC Proteins D12.776.785.680 D12.776.785.340.500 PrPSc Proteins ...
Equilibrative Nucleoside Transport Proteins D12.776.157.530.937.532 D12.776.543.585.937.563 Equilibrative Nucleoside ... Protein Transport G3.495.166.700 G3.143.700 Protein Unfolding G1.154.100.640.750 G1.154.651.750 G1.595.100.640.750 G2.111. ... ELAV Proteins D12.776.641.520 D12.776.631.520 ELAV-Like Protein 2 D12.776.641.520.500 D12.776.631.520.500 ELAV-Like Protein 3 ... PrP 27-30 Protein D12.776.785.700.700 D12.776.785.340.750.700 PrPC Proteins D12.776.785.680 D12.776.785.340.500 PrPSc Proteins ...
Equilibrative Nucleoside Transport Proteins D12.776.157.530.937.532 D12.776.543.585.937.563 Equilibrative Nucleoside ... Protein Transport G3.495.166.700 G3.143.700 Protein Unfolding G1.154.100.640.750 G1.154.651.750 G1.595.100.640.750 G2.111. ... ELAV Proteins D12.776.641.520 D12.776.631.520 ELAV-Like Protein 2 D12.776.641.520.500 D12.776.631.520.500 ELAV-Like Protein 3 ... PrP 27-30 Protein D12.776.785.700.700 D12.776.785.340.750.700 PrPC Proteins D12.776.785.680 D12.776.785.340.500 PrPSc Proteins ...
Equilibrative Nucleoside Transport Proteins D12.776.157.530.937.532 D12.776.543.585.937.563 Equilibrative Nucleoside ... Protein Transport G3.495.166.700 G3.143.700 Protein Unfolding G1.154.100.640.750 G1.154.651.750 G1.595.100.640.750 G2.111. ... ELAV Proteins D12.776.641.520 D12.776.631.520 ELAV-Like Protein 2 D12.776.641.520.500 D12.776.631.520.500 ELAV-Like Protein 3 ... PrP 27-30 Protein D12.776.785.700.700 D12.776.785.340.750.700 PrPC Proteins D12.776.785.680 D12.776.785.340.500 PrPSc Proteins ...
On the contrary, "protein-heme linkage," "regulation of transcription DNA-dependent," "nucleoside metabolic process," and " ... The GO categories of "cell redox homeostasis," "intracellular protein transport," "phosphatidylinositol phosphorylation," " ... 2009). Abscisic acid inhibits type 2C protein phosphatases via the PYR/PYL family of START proteins. Science 324, 1068-1071. ... which is carried out by proteins coded by sugar transporter genes. They ensure sugar transport from the source (leaves) to the ...
... on the classical organic anion system and transport of fluorescein-methotrexate on multidrug resistance-associated protein 2 ( ... multidrug resistance-associated protein 2. OAT. organic anion transporter. FL-MTX. fluorescein-methotrexate. FL. fluorescein. ... Nucleoside Phosphonate Interactions with Multiple Organic Anion Transporters in Renal Proximal Tubule. David S. Miller ... Nucleoside Phosphonate Interactions with Multiple Organic Anion Transporters in Renal Proximal Tubule. David S. Miller ...
F:protein binding, nucleoside-triphosphatase activity, ATPase activity, nucleotide binding, ATP binding;P:protein transport;C: ... protein kinase family protein. F:protein serine/threonine kinase activity, protein kinase activity, kinase activity, ATP ... Binding protein, : Enzyme protein, : Other protein. : VF over 0.50, : over 0.25, : below 0.25. Co-expressed genes. Click gene/ ... CwfJ-like family protein / zinc finger (CCCH-type) family protein. F:zinc ion binding, catalytic activity, nucleic acid binding ...
NONH for all modes of transport. Specifications and Other Information of Our Diaphorase CAS UENA-0247. Protein purity. >90% by ... Copyright © 2023 Ulcho Biochemical Ltd - Expert in Carbohydrate, Nucleotide, Nucleoside and Ionic Liquid , A FCAD Company # ...
The PHYRE automatic fold recognition server for predicting the structure and/or function of your protein sequence. ... transport protein Chain: A: nucleoside permease nupg; c7d6xA_. 2.88 oxidoreductase Chain: A: succinate dehydrogenase subunit a ... protein transport Chain: E: lipoprotein-releasing system transmembrane protein lole; c7c4cA_. 2.27 rna binding protein Chain: A ... protein transport Chain: F: lipoprotein-releasing system atp-binding protein lold; c7d6xB_. 2.88 oxidoreductase Chain: B: ...
Dopamine Plasma Membrane Transport Proteins. *Equilibrative Nucleoside Transport Proteins. *Glucose Transport Proteins, ... "Organic Anion Transport Protein 1" by people in this website by year, and whether "Organic Anion Transport Protein 1" was a ... "Organic Anion Transport Protein 1" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ... Below are the most recent publications written about "Organic Anion Transport Protein 1" by people in Profiles. ...

No FAQ available that match "nucleoside transport proteins"

No images available that match "nucleoside transport proteins"